Cyclooxygenase inhibitors attenuate endothelin ETB receptor-mediated contraction in human temporal artery
- 12 July 2002
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 448 (1), 51-57
- https://doi.org/10.1016/s0014-2999(02)01894-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Coxibs, Selective Inhibitors of Cyclooxygenase-2The New England Journal of Medicine, 2001
- Cerebral ischemia and inflammationCurrent Opinion in Neurology, 2001
- Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to IschemiaBrain Pathology, 2000
- Role of Protein Kinase Cα and Mitogen-Activated Protein Kinases in Endothelin-1-Stimulation of Cytosolic Phospholipase A2 in Iris Sphincter Smooth MuscleJournal of Cardiovascular Pharmacology, 2000
- Cytokines increase endothelin ETB receptor contractile activity in rat cerebral arteryNeuroReport, 1999
- Essential role for endothelin ETBreceptors in fever induced by LPS (E. coli) in ratsBritish Journal of Pharmacology, 1998
- Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture.Cardiovascular Research, 1998
- Plasticity of contractile endothelin‐B receptors in human arteries after organ cultureBritish Journal of Pharmacology, 1996
- Endothelin ET A and ET B Receptors Cause Vasoconstriction of Human Resistance and Capacitance Vessels In VivoCirculation, 1995
- Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub‐typeBritish Journal of Pharmacology, 1995